| P2093 | author name string | Zheng Yuan | |
| | Wen-Tao Li | |
| | Wei-Jun Peng | |
| | Xiao-Dan Ye | |
| | Xiang-Sheng Xiao | |
| P2860 | cites work | Global cancer statistics | Q22241238 |
| | Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver | Q29616866 |
| | Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial | Q29617955 |
| | Changes in water mobility measured by diffusion MRI predict response of metastatic breast cancer to chemotherapy | Q30983132 |
| | Diffusion-weighted MRI in the body: applications and challenges in oncology | Q31113294 |
| | Malignant transformation of adenomatous hyperplasia to hepatocellular carcinoma | Q34612150 |
| | Nephrogenic systemic fibrosis: risk factors and incidence estimation. | Q36724438 |
| | Diffusion-weighted imaging in tissues: theoretical models | Q36811124 |
| | Focal liver lesion detection and characterization with diffusion-weighted MR imaging: comparison with standard breath-hold T2-weighted imaging | Q37068523 |
| | Practical aspects of assessing tumors using clinical diffusion-weighted imaging in the body | Q37073379 |
| | Unresectable hepatocellular carcinoma: serial early vascular and cellular changes after transarterial chemoembolization as detected with MR imaging. | Q37383964 |
| | Liver lesion detection and characterization: role of diffusion-weighted imaging. | Q38109869 |
| | MDCT versus MRI assessment of tumor response after transarterial chemoembolization for the treatment of hepatocellular carcinoma | Q43257019 |
| | Relationship of apparent diffusion coefficient to survival for patients with unresectable primary hepatocellular carcinoma after chemoembolization. | Q51058878 |
| | Assessment of tumor necrosis of hepatocellular carcinoma after chemoembolization: diffusion-weighted and contrast-enhanced MRI with histopathologic correlation of the explanted liver. | Q51791527 |
| | Improved focal liver lesion detection: comparison of single-shot diffusion-weighted echoplanar and single-shot T2 weighted turbo spin echo techniques. | Q51914314 |
| | Evaluating local hepatocellular carcinoma recurrence post-transcatheter arterial chemoembolization: is diffusion-weighted MRI reliable as an indicator? | Q53036413 |
| | Diffusion-weighted imaging of the liver: comparison of navigator triggered and breathhold acquisitions. | Q53059807 |
| | Imaging features of hepatocellular carcinoma after transcatheter arterial chemoembolization and radiofrequency ablation. | Q53519828 |
| | Predicting Response of Colorectal Hepatic Metastasis: Value of Pretreatment Apparent Diffusion Coefficients | Q57551329 |
| | Black-Blood Diffusion-Weighted EPI Acquisition of the Liver with Parallel Imaging | Q61855611 |
| | Role of diffusion-weighted imaging in estimating tumor necrosis after chemoembolization of hepatocellular carcinoma | Q73838246 |
| | Abdomen: diffusion-weighted MR imaging with pulse-triggered single-shot sequences | Q74390316 |
| | Hepatic metastases: diffusion-weighted sensitivity-encoding versus SPIO-enhanced MR imaging | Q82625559 |
| | Role of magnetic resonance diffusion-weighted imaging in evaluating response after chemoembolization of hepatocellular carcinoma | Q84090986 |
| P433 | issue | 2 | |
| P921 | main subject | hepatocellular carcinoma | Q1148337 |
| P304 | page(s) | 831-836 | |
| P577 | publication date | 2014-06-05 | |
| P1433 | published in | Oncology Letters | Q20640514 |
| P1476 | title | Utility of diffusion-weighted imaging to assess hepatocellular carcinoma viability following transarterial chemoembolization | |
| P478 | volume | 8 | |